Genmab Feed

Land	Danmark
Lista	Large Cap Copenhagen
Sektor	Hälsovård
Industri	Bioteknik

2022-10-05 21:56:40 Major Shareholder Announcement

2022-09-27 18:43:29 Capital Increase in Genmab as a Result of Employee Warrant Exercise +0,57% | 234 MDKK

2022-09-20 21:20:55 Grant of Restricted Stock Units and Warrants to Employees in Genmab +1,12% | 176 MDKK

2022-09-06 16:53:48 Genmab to Present at Morgan Stanley 20th Annual Global Healthcare Conference -0,19% | 187 MDKK

2022-09-01 18:27:13 Completion of share buy-back program +3,70% | 339 MDKK

2022-08-29 11:04:41 Transactions in connection with share buy-back program -2,87% | 274 MDKK

2022-08-24 20:52:50 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons -0,22% | 264 MDKK

2022-08-22 11:50:04 Transactions in connection with share buy-back program -0,79% | 217 MDKK

2022-08-17 19:19:34 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons -2,11% | 209 MDKK

2022-08-16 20:26:13 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons +0,26% | 235 MDKK

2022-08-16 20:22:37 Capital Increase in Genmab as a Result of Employee Warrant Exercise +0,26% | 235 MDKK

2022-08-15 09:42:26 Transactions in connection with share buy-back program +2,12% | 195 MDKK

2022-08-10 17:01:39 Genmab Announces Financial Results for the First Half of 2022 +5,38% | 543 MDKK

2022-08-08 18:33:17 Genmab Improves Its 2022 Financial Guidance +0,23% | 233 MDKK

2022-08-08 10:18:18 Transactions in connection with share buy-back program +0,27% | 236 MDKK

2022-08-05 12:45:00 Genmab and BioNTech Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates -2,37% | 290 MDKK

2022-08-02 20:46:23 Major Shareholder Announcement +1,46% | 309 MDKK

2022-08-01 13:41:29 Transactions in connection with share buy-back program -0,12% | 311 MDKK

2022-07-25 13:50:01 Transactions in connection with share buy-back program -2,23% | 230 MDKK

2022-07-20 19:03:08 Major Shareholder Announcement +1,40% | 245 MDKK

2022-07-19 12:33:55 Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Second Quarter of 2022 +2,25% | 387 MDKK

2022-07-18 16:01:41 Genmab Announces That AbbVie Will Submit Marketing Authorization Application to European Medicines Agency for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) -0,04% | 176 MDKK

2022-07-18 13:27:45 Transactions in connection with share buy-back program -0,04% | 176 MDKK

2022-07-11 17:28:06 Major Shareholder Announcement -1,64% | 262 MDKK

2022-07-11 10:50:43 Transactions in connection with share buy-back program +0,12% | 182 MDKK

2022-07-05 20:05:20 Capital Increase in Genmab as a Result of Employee Warrant Exercise +0,33% | 343 MDKK

2022-07-04 10:16:14 Transactions in connection with share buy-back program -0,34% | 134 MDKK

2022-07-01 16:15:00 Major Shareholder Announcement +2,79% | 303 MDKK

2022-06-30 20:24:53 Genmab to Submit Biologics License Application to U.S. Food and Drug Administration for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) +2,79% | 303 MDKK

2022-06-27 10:09:42 Transactions in connection with share buy-back program +1,79% | 230 MDKK

2022-06-23 17:55:39 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons +3,19% | 301 MDKK

2022-06-20 16:35:57 Major Shareholder Announcement +1,89% | 159 MDKK

2022-06-17 16:38:32 Genmab Announces Initiation of Share Buy-Back Program +5,92% | 402 MDKK

2022-06-11 14:45:00 Genmab Announces Late-Breaking Phase 2 Trial Results of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Relapsed/Refractory Large B-cell Lymphoma (LBCL) Patients Presented at European Hematology Association (EHA) Presidential Symposium -3,73% | 268 MDKK

2022-06-09 23:17:08 Genmab Commences New Arbitration Under License Agreement With Janssen -1,76% | 214 MDKK

2022-06-09 20:57:38 Grant of Restricted Stock Units and Warrants to Employees in Genmab -1,76% | 214 MDKK

2022-06-08 20:32:20 Genmab to Participate in a Fireside Chat at the Goldman Sachs 43rd Annual Global Healthcare Conference -3,44% | 137 MDKK

2022-06-06 17:00:00 Genmab and Seagen Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at ASCO 2022 Annual Meeting +1,19% | 198 MDKK

2022-06-01 18:21:19 Major Shareholder Announcement -0,91% | 145 MDKK

2022-05-26 23:00:00 Genmab Announces Multiple Abstracts to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting +2,84% | 254 MDKK

2022-05-17 20:32:13 Capital Increase in Genmab as a Result of Employee Warrant Exercise +1,24% | 321 MDKK

2022-05-12 16:00:00 Genmab Announces Multiple Abstracts to be Presented at the European Hematology Association (EHA) Annual Congress -1,31% | 437 MDKK

2022-05-11 17:01:38 Genmab Announces Financial Results for the First Quarter of 2022 -1,31% | 437 MDKK

2022-04-19 12:29:33 Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2022 +2,94% | 653 MDKK

2022-04-13 23:25:00 Genmab and AbbVie Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) From Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL) +2,94% | 653 MDKK

2022-04-08 01:44:25 Genmab Announces the Initial Resolution of its Arbitration with Janssen Relating to their Daratumumab License Agreement +2,66% | 322 MDKK

2022-03-29 20:34:48 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons +2,99% | 338 MDKK

2022-03-29 20:29:02 Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to the New Member of the Board of Directors and Grant of Restricted Stock Units and Warrants to Employees in Genmab +2,99% | 338 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2022-11-09	Kvartalsrapport 2022-Q3
2022-08-10	Kvartalsrapport 2022-Q2
2022-05-11	Kvartalsrapport 2022-Q1
2022-03-30	Ordinarie utdelning GMAB 0.00 DKK
2022-03-29	Årsstämma 2022
2022-02-16	Bokslutskommuniké 2021
2021-11-10	Kvartalsrapport 2021-Q3
2021-08-11	Kvartalsrapport 2021-Q2
2021-05-05	Kvartalsrapport 2021-Q1
2021-04-14	Ordinarie utdelning GMAB 0.00 DKK
2021-04-13	Årsstämma 2021
2021-02-23	Bokslutskommuniké 2020
2020-11-04	Kvartalsrapport 2020-Q3
2020-08-12	Kvartalsrapport 2020-Q2
2020-05-06	Kvartalsrapport 2020-Q1
2020-03-27	Ordinarie utdelning GMAB 0.00 DKK
2020-03-26	Årsstämma 2020
2020-02-19	Bokslutskommuniké 2019
2019-04-01	Ordinarie utdelning GMAB 0.00 DKK
2019-03-29	Årsstämma 2019
2018-11-14	Kvartalsrapport 2018-Q3
2018-08-08	Kvartalsrapport 2018-Q2
2018-05-08	Kvartalsrapport 2018-Q1
2018-04-11	Ordinarie utdelning GMAB 0.00 DKK
2018-04-10	Årsstämma 2018
2018-02-21	Bokslutskommuniké 2017
2017-11-08	Kvartalsrapport 2017-Q3
2017-08-09	Kvartalsrapport 2017-Q2
2017-05-10	Kvartalsrapport 2017-Q1
2017-03-29	Ordinarie utdelning GMAB 0.00 DKK
2017-03-28	Årsstämma 2017
2017-02-22	Bokslutskommuniké 2016
2016-11-10	Kapitalmarknadsdag 2016
2016-11-02	Kvartalsrapport 2016-Q3
2016-08-09	Kvartalsrapport 2016-Q2
2016-05-10	Kvartalsrapport 2016-Q1
2016-03-18	Ordinarie utdelning GMAB 0.00 DKK
2016-03-17	Årsstämma 2016
2016-02-17	Bokslutskommuniké 2015
2015-11-03	Kvartalsrapport 2015-Q3
2015-08-11	Kvartalsrapport 2015-Q2
2015-05-12	Kvartalsrapport 2015-Q1
2015-03-27	Ordinarie utdelning GMAB 0.00 DKK
2015-03-26	Årsstämma 2015
2015-03-02	Bokslutskommuniké 2014
2014-04-10	Ordinarie utdelning GMAB 0.00 DKK
2013-04-18	Ordinarie utdelning GMAB 0.00 DKK
2012-04-26	Ordinarie utdelning GMAB 0.00 DKK
2011-04-07	Ordinarie utdelning
2010-04-22	Ordinarie utdelning

Genmab

Beskrivning

Kalender

Genmab

Beskrivning

Kalender

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden